 | Up a level |
Rentsch, K; Eap, CB; Fathi, M; Grignaschi, M; Magnin, JL; Thormann, W; Todesco, L; Werner, D (2009). Monographs on drugs which are frequently analyzed in therapeutic drug monitoring. LaboratoriumsMedizin / Journal of laboratory medicine, 33(2), pp. 99-120. Berlin: De Gruyter 10.1515/JLM.2009.014
Colombo, S; Buclin, T; Décosterd, LA; Telenti, A; Furrer, H; Lee, BL; Biollaz, J; Eap, CB; Swiss, HIV Cohort Study (2006). Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation. Clinical pharmacology & therapeutics, 80(4), pp. 307-18. New York, N.Y.: Nature Publishing Group 10.1016/j.clpt.2006.06.006
Begré, S; von Bardeleben, U; Ladewig, D; Jaquet-Rochat, S; Cosendai-Savary, L; Golay, KP; Kosel, M; Baumann, P; Eap, CB (2002). Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers. Journal of Clinical Psychopharmacology, 22(2), pp. 211-5. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/00004714-200204000-00017
